glp 1 and graves disease Glucagon-like peptide receptor agonist use risk of thyroid cancer: Scandinavian cohort study GLP-1RA and thyroid cancer: New

Stay tuned next week on 23rd December for the full 2026 Health Populi TrendCast with a focus on digital health trends we anticipate will set the stage for CES 2026

The Australia GLP-1 receptor agonist market size was valued at USD 570.49 million in 2025 and is expected to hit around USD 2,117.46 million by 2035, growing at a CAGR of 14.01% from 2026 to 2035.

Lisa S

A clinically positioned GLP-1 metabolic support product provides a credible foundation for building a broader brand ecosystem that may include gut health, muscle preservation, collagen support, energy optimization, and longevity nutrition

GLP-1 is a hormone that the gut produces after eating to regulate blood sugar, slow digestion and manage hunger

If you came to struggle with gastroparesis, bowe obstruction or vision loss as a result of using Victoza, you might be eligible to file a claim with the manufacturer, which can help you obtain financial compensation